CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,275 | -72.3% | 119 | -65.9% | 0.00% | – |
| Q2 2023 | $11,842 | -18.9% | 349 | -14.0% | 0.00% | – |
| Q1 2023 | $14,608 | -19.3% | 406 | 0.0% | 0.00% | – |
| Q4 2022 | $18,095 | +64.5% | 406 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | 0.0% | 406 | 0.0% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 406 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 406 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -27.3% | 406 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +57.1% | 406 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | +75.0% | 406 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 406 | +14.0% | 0.00% | – |
| Q4 2020 | $6,000 | – | 356 | +5833.3% | 0.00% | – |
| Q2 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |